The Georgia Research Alliance (GRA) expands research and commercialization capacity in Georgia’s universities to launch new companies,
Business Model:
Revenue: $500M
Employees: 51-200
Address: 270 Peachtree Street NW
City: Atlanta
State: GA
Zip: 30303
Country: US
The Georgia Research Alliance (GRA) expands research and commercialization capacity in Georgia’s universities to launch new companies, create high-value jobs and transform lives. Since its formation in 1990, GRA has leveraged over $600 million of state funding into: $2.6 billion of direct federal and private investment in Georgia 150+ newly launched companies 6,000+ high-skill, high-value jobs a portfolio of inventions, processes and technologies that benefit humankind GRA is an independent nonprofit (501c3) organization closely aligned with Georgia’s Department of Economic Development and works with the following partner universities: University of Georgia, Georgia Regents University, Emory University, Clark Atlanta University, Georgia Institute of Technology, Georgia State University, Mercer University and Morehouse School of Medicine.
Contact Phone:
+14043329770
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2016 | RePredix | Grant | 44k |
11/2008 | Inhibikase Therapeutics | Grant | 55.6k |
1/2016 | Corami Therapeutics | Grant | 58.2k |
10/2014 | Abby Med | Grant | 110k |
2/2019 | Cognition Medical | Grant | 66k |
4/2012 | Cambium Medical Technologies | Grant | 25k |
1/2019 | Neovaccine Strategies | Grant | 50k |
1/2011 | Whisper Communications | Grant | 48k |
9/2017 | NatGlycan | Grant | 25k |
1/2018 | Centizyme | Grant | 35.2k |
5/2017 | Nutrivert | Grant | 23.8k |
11/2010 | NeurOp | Grant | 150k |
3/2005 | NeurOp | Grant | 50k |
10/2011 | NeurOp | Grant | 100k |
9/2013 | QUE Oncology | Grant | 119k |
2/2013 | QUE Oncology | Grant | 25k |
10/2012 | QUE Oncology | Grant | 25k |
7/2014 | QUE Oncology | Grant | 98.9k |
5/2014 | NovAb | Grant | 50k |
12/2012 | NovAb | Grant | 25k |
7/2007 | Velocity Medical Solutions | Grant | 100k |
11/2015 | TendoNova | Grant | 49.3k |
8/2017 | TendoNova | Grant | 43.6k |
3/2019 | TendoNova | Grant | 36k |
5/2014 | Cambium Medical Technologies | Grant | 60k |
7/2014 | CloudTags | Grant | 15k |
1/2007 | Velocity Medical Solutions | Grant | 50k |
12/2005 | Velocity Medical Solutions | Grant | 50k |
3/2019 | Sequegenics | Grant | 32.5k |
3/2017 | DIASYST Inc. | Grant | 50k |
3/2014 | Sanguina | Grant | 25k |
2/2019 | Lucid Scientific | Grant | 26.4k |
4/2016 | NovAb | Grant | 100k |
5/2018 | PDx Scan | Grant | 17.5k |
5/2017 | Sanguina | Grant | 61k |
2/2013 | Sanguina | Grant | 13k |
7/2014 | Nyra Medical | Grant | 52.3k |
4/2016 | Nyra Medical | Grant | 20k |
4/2009 | NeurOp | Grant | 50k |
1/2012 | AKESOgen | Grant | 150k |
9/2013 | Behavioral Science Technologies | Grant | 22.8k |
10/2011 | Nyra Medical | Grant | 10k |
2/2011 | AKESOgen | Grant | 50k |
10/2011 | AKESOgen | Grant | 100k |
12/2014 | NovAb | Grant | 150k |
4/2012 | NovAb | Grant | 25k |
3/2018 | RePredix | Grant | 36k |
3/2020 | Aviabiotic | Grant | 0 |
9/2014 | AlphaStem | Grant | 82.7k |
8/2005 | NeurOp | Grant | 50k |
7/2012 | AlphaStem | Grant | 4k |
3/2016 | DIASYST Inc. | Grant | 50k |
4/2015 | LymphaTech | Seed Round | - |
8/2018 | Centizyme | Grant | 10k |
7/2016 | MoQuality | Grant | 275k |
10/2011 | Cambium Medical Technologies | Grant | 25k |
10/2009 | Inhibikase Therapeutics | Grant | 50k |
12/2016 | Covanos | Grant | 49.9k |
1/2015 | CloudTags | Grant | 75k |
11/2022 | Nyra Medical | Series A | 20M |
3/2017 | Urjanet | Series C | 0 |
10/2017 | Abby Med | Grant | 40.6k |
8/2019 | HAWA Therapeutics | Seed Round | 25k |
11/2022 | Nyra Medical | Series A | 0 |
11/2018 | Antios Therapeutics | Series A | 0 |
9/2014 | Clearside Biomedical | Series B | 16M |
11/2017 | Centizyme | Grant | 10k |
12/2006 | Velocity Medical Solutions | Grant | 25k |
7/2017 | RePredix | Grant | 25k |
8/2019 | Pyrefin | Grant | 52.6k |
2/2017 | Sophia Bioscience | Grant | 59.2k |
8/2019 | Proxime | Grant | 40.1k |
2/2018 | Proxime | Grant | 27k |
4/2018 | BioPace | Grant | 54.5k |
1/2012 | Nyra Medical | Grant | 25k |
2/2019 | Aviabiotic | Grant | 30k |
3/2014 | AngioCloud | Grant | 54.4k |
11/2019 | PNP Therapeutics | Grant | 50k |
11/2011 | Metaclipse Therapeutics | Grant | 25k |
2/2020 | Focused Cryo | Grant | 0 |
9/2016 | Nyra Medical | Grant | 74.9k |
1/2020 | Nyra Medical | Grant | 0 |
2/2020 | Focused Cryo | Grant | 0 |
9/2008 | Inhibikase Therapeutics | Grant | 25k |
3/2020 | Neovaccine Strategies | Grant | 0 |
7/2017 | NanoV Therapeutics | Grant | 24.8k |
2/2018 | Oncospherix | Grant | 22.4k |
4/2019 | Oncospherix | Grant | 41.6k |
1/2019 | Migra Therapeutics | Grant | 51.7k |
7/2010 | Inhibikase Therapeutics | Grant | 150k |
8/2016 | CellectCell | Grant | - |
10/2015 | CellectCell | Grant | - |
12/2019 | Focused Cryo | Grant | 0 |
11/2008 | Inhibikase Therapeutics | Grant | 25k |
11/2017 | Covanos | Grant | 39k |
6/2016 | MicroBplex | Grant | 100k |
12/2015 | Covanos | Grant | 80.5k |
3/2018 | Covanos | Grant | 40k |
2/2018 | Cognition Medical | Grant | 84k |
7/2018 | BioPace | Grant | 105.2k |
5/2014 | MicroBplex | Grant | 73k |
7/2012 | MicroBplex | Grant | 25k |
9/2014 | RSV NewCo | Grant | 50k |
11/2015 | Accuitis | Seed Round | 0 |
7/2010 | Iconic Therapeutics | Grant | 100k |
3/2014 | Abby Med | Grant | 34k |
9/2017 | MicroBplex | Grant | 50.7k |
3/2018 | Migra Therapeutics | Grant | 35.8k |
1/2016 | Codoxo | Grant | 0 |
12/2016 | Neurotrack | Grant | 800k |
4/2010 | Iconic Therapeutics | Grant | 150k |
3/2016 | Sequegenics | Grant | 47.5k |
7/2012 | Sanguina | Grant | 25k |
1/2010 | Iconic Therapeutics | Grant | 50k |
7/2019 | Kodikaz Therapeutic Solutions | Grant | 50k |
1/2020 | BioData Consortium | Grant | 20k |
4/2017 | Corami Therapeutics | Grant | 29.9k |
5/2015 | Corami Therapeutics | Grant | 11.8k |
10/2017 | Corami Therapeutics | Grant | 41.9k |
7/2019 | BioData Consortium | Grant | 25k |
3/2017 | Sequegenics | Grant | 65k |
7/2019 | Lucid Scientific | Grant | 58.5k |
8/2009 | Iconic Therapeutics | Grant | 48k |
9/2011 | Inhibikase Therapeutics | Grant | 100k |
9/2017 | Reservoir | Grant | 25k |
3/2016 | Sanguina | Grant | 81k |
9/2006 | Velocity Medical Solutions | Grant | 50k |
11/2015 | QUE Oncology | Grant | 100k |
7/2015 | QUE Oncology | Grant | 150k |
1/2011 | AKESOgen | Grant | 50k |
6/2018 | Lucid Scientific | Grant | 23.9k |
12/2016 | NatGlycan | Grant | 25k |
7/2012 | Metaclipse Therapeutics | Grant | 57.5k |
4/2012 | Metaclipse Therapeutics | Grant | 42k |
11/2010 | Metaclipse Therapeutics | Grant | 25k |
1/2019 | DIASYST Inc. | Grant | 50k |
6/2016 | DIASYST Inc. | Grant | 50k |
6/2011 | LiquidText | Grant | - |
9/2006 | NeurOp | Grant | 25k |
6/2017 | Covanos | Grant | 75k |
3/2020 | AngioCloud | Grant | 34.3k |
2/2022 | EarliTec Diagnostics | Series A | 19.5M |
9/2019 | TendoNova | Grant | 69k |
1/2019 | MapHabit | Grant | 48.4k |
8/2021 | TendoNova | Seed Round | 250k |
10/2018 | MapHabit | Grant | 58.5k |
12/2008 | Velocity Medical Solutions | Grant | 150k |
11/2013 | MedShape | Seed Round | - |
6/2017 | BioPace | Grant | 30.3k |
5/2015 | MetCure Therapeutics | Grant | - |
2/2019 | Pyrefin | Grant | 48.1k |
6/2018 | Oncospherix | Grant | 53.4k |
8/2009 | Inhibikase Therapeutics | Grant | 50k |
7/2018 | PNP Therapeutics | Grant | 50k |
1/2018 | Celtaxsys | Series E | - |
3/2019 | Abby Med | Grant | 50.6k |
2/2022 | EarliTec Diagnostics | Series A | 0 |
3/2020 | Aviabiotic | Grant | 0 |
3/2020 | AngioCloud | Grant | 0 |
3/2020 | Neovaccine Strategies | Grant | 0 |
2/2020 | Focused Cryo | Grant | 0 |
2/2020 | Focused Cryo | Grant | 0 |
1/2020 | Nyra Medical | Grant | 0 |
1/2020 | BioData Consortium | Grant | 0 |
12/2019 | Focused Cryo | Grant | 0 |
11/2019 | PNP Therapeutics | Grant | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|